CATALOGO DEI PRODOTTI DELLA RICERCA

LUPO, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.046
EU - Europa 12.299
AS - Asia 8.860
SA - Sud America 1.238
AF - Africa 165
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 14
Totale 36.643
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.837
RU - Federazione Russa 4.088
SG - Singapore 3.730
GB - Regno Unito 2.948
CN - Cina 2.607
BR - Brasile 1.004
IT - Italia 966
SE - Svezia 929
VN - Vietnam 768
DE - Germania 756
FR - Francia 741
IE - Irlanda 681
FI - Finlandia 657
HK - Hong Kong 643
KR - Corea 315
UA - Ucraina 219
BD - Bangladesh 172
IN - India 121
CA - Canada 97
AR - Argentina 91
JP - Giappone 76
ID - Indonesia 65
TR - Turchia 62
MX - Messico 54
IQ - Iraq 53
BE - Belgio 50
NL - Olanda 45
AT - Austria 41
NG - Nigeria 41
EC - Ecuador 38
ZA - Sudafrica 38
ES - Italia 34
PL - Polonia 32
CO - Colombia 27
IL - Israele 25
VE - Venezuela 24
UZ - Uzbekistan 23
MA - Marocco 22
PK - Pakistan 22
AU - Australia 19
PY - Paraguay 18
EG - Egitto 17
AE - Emirati Arabi Uniti 16
CL - Cile 16
SA - Arabia Saudita 16
MY - Malesia 14
PH - Filippine 14
TH - Thailandia 13
AZ - Azerbaigian 12
CZ - Repubblica Ceca 11
EU - Europa 11
LT - Lituania 11
GR - Grecia 10
JM - Giamaica 10
JO - Giordania 10
KZ - Kazakistan 10
TN - Tunisia 10
CH - Svizzera 9
RO - Romania 9
BH - Bahrain 8
KE - Kenya 8
NP - Nepal 8
PA - Panama 8
BO - Bolivia 7
CR - Costa Rica 7
HR - Croazia 7
PE - Perù 7
RS - Serbia 7
AL - Albania 6
HN - Honduras 6
IR - Iran 6
KG - Kirghizistan 6
NI - Nicaragua 6
OM - Oman 6
PS - Palestinian Territory 6
PT - Portogallo 6
DK - Danimarca 5
DO - Repubblica Dominicana 5
ET - Etiopia 5
KH - Cambogia 5
LV - Lettonia 5
SN - Senegal 5
UY - Uruguay 5
CG - Congo 4
DZ - Algeria 4
HU - Ungheria 4
LB - Libano 4
SV - El Salvador 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
AM - Armenia 3
BB - Barbados 3
BG - Bulgaria 3
BY - Bielorussia 3
LA - Repubblica Popolare Democratica del Laos 3
LK - Sri Lanka 3
NO - Norvegia 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
XK - ???statistics.table.value.countryCode.XK??? 3
Totale 36.606
Salva come PNG Salva come JPEG
Città #
Southend 2.455
Singapore 1.984
Jacksonville 1.892
Chandler 1.442
Ashburn 1.428
Moscow 1.246
San Jose 1.152
Woodbridge 901
Dallas 798
Ann Arbor 714
Dublin 678
Hong Kong 635
Houston 545
Verona 400
The Dalles 378
Beijing 369
Wilmington 285
Lawrence 268
Princeton 268
New York 249
Council Bluffs 239
Los Angeles 206
Jinan 198
Ho Chi Minh City 196
Nanjing 173
Shenyang 166
Buffalo 160
Hanoi 147
Helsinki 132
Boardman 119
Tianjin 115
Hebei 106
Dong Ket 101
São Paulo 98
Sindelfingen 89
Santa Clara 87
Columbus 84
Milan 75
Tokyo 72
Ningbo 66
Changsha 64
Haikou 63
Orem 63
Guangzhou 62
Zhengzhou 62
Redondo Beach 61
Nanchang 58
Munich 55
Jiaxing 52
Brussels 50
Hangzhou 50
Seattle 48
Lancaster 47
Taizhou 44
Falls Church 41
Seoul 40
Abuja 39
San Francisco 38
Taiyuan 38
Chicago 37
Jakarta 37
Philadelphia 36
Rio de Janeiro 35
Norwalk 34
Lanzhou 33
London 32
Rome 32
Toronto 31
Chennai 29
Montreal 29
Nuremberg 29
Atlanta 28
Turku 28
Frankfurt am Main 27
Washington 27
Auburn Hills 26
Brooklyn 26
Vienna 26
Warsaw 26
Denver 25
Phoenix 25
Kent 23
Da Nang 22
Detroit 22
Haiphong 22
Baghdad 21
Johannesburg 21
Quito 21
Redmond 21
Amsterdam 20
Fairfield 20
Fuzhou 20
Mumbai 18
Redwood City 18
Venice 18
Belo Horizonte 17
Biên Hòa 17
Tashkent 17
Bologna 16
Dhaka 16
Totale 22.719
Salva come PNG Salva come JPEG
Nome #
Proteomic Analysis of Urinary Microvesicles and Exosomes in Medullary Sponge Kidney Disease and Autosomal Dominant Polycystic Kidney Disease. 291
125I-iothalamate and creatinine clearances in patients with chronic renal diseases 286
DISREGOLAZIONE DELLA BIOSINTESI E DEL METABOLISMO DEI PROTEOGLICANI/GLICOSAMINOGLICANI NEI SOGGETTI UREMICI: UNO STUDIO DI GENOMICA FUNZIONALE 260
Eparanasi: un nuovo biomarker di fibrosi e un potenziale target farmacologico per ridurre la progressione del danno renale cronico 259
Low platelet glutathione peroxidase activity and serum selenium concentration in patients with chronic renal failure: relations to dialysis treatments, diet and cardiovascular complications 250
Adding access blood flow surveillance to clinical monitoring reduces thrombosis rates and costs, and improves fistula patency in the short term: a controlled cohort study. 226
Endovascular versus Surgical Preemptive Repair of Forearm Arteriovenous Fistula Juxta-Anastomotic Stenosis: Analysis of Data Collected Prospectively from 1999 to 2004 218
A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy. 211
A napkin-associated outbreak of Burkholderia cenocepacia bacteraemia in haemodialysis patients. 211
Cutaneous plasmacytoma in a hemodialysis patient. 210
A single dialysis session of hemodiafiltration with sorbent-regenerated endogenous ultrafiltrate reinfusion (HFR) removes hepcidin more efficiently than bicarbonate hemodialysis: a new approach to containing hepcidin burden in dialysis patients? 207
Terapia della glomerulonefrite membrano proliferativa. 206
Long-Term (3 Years) Prognosis of Contrast-Induced Acute Kidney Injury After Coronary Angiography 206
IDENTIFICATION OF MOLECULAR BIOMARKERS FOR EARLY DIAGNOSIS OF DELAYED GRAFT FUNCTION IN RENAL TRANSPLANT RECIPIENTS 205
14-year experience with the double-cuff straight Tenckhoff catheter 204
A prospective, randomized trial of two antibiotic regimens in the treatment of peritonitis in CAPD patients: Teicoplanin plus tobramycin versus cephalothin plus tobramycin 204
A new mechanism of action of sulodexide in diabetic nephropathy: inhibits heparanase-1 and prevents FIG-2-induced renal epithelial-mesenchymal transition. 200
Alterations in renal tubular sodium and water transport in polycystic kidney disease 197
Prevalence of CKD in northeastern Italy: results of the INCIPE study and comparison with NHANES. 197
Comparison of serum creatinine and cystatin C for early diagnosis of contrast-induced nephropathy after coronary angiography and interventions. 196
Hairy cell leukemia in kidney transplantation: lesson from a rare disorder. 196
A specific immune transcriptomic profile discriminates chronic kidney disease patients in predialysis from hemodialyzed patients. 196
Outcomes of the surgical revision of stenosed and thrombosed forearm arteriovenous fistulae for hemodialysis 194
Anaemia in diabetic renal failure: is there a role for early erythropoietin treatment in preventing cardiovascular mortality? 189
Aspects of calcium metabolism in obstructive nephropathy: a metabolic and bone biopsy investigation 186
In Vitro Identification of New Transcriptomic and miRNomic Profiles Associated with Pulmonary Fibrosis Induced by High Doses Everolimus: Looking for New Pathogenetic Markers and Therapeutic Targets. 186
Can blood flow surveillance and pre-emptive repair of subclinical stenosis prolong the useful life of arteriovenous fistulae? A randomized controlled study 185
mTOR inhibitors and renal allograft: Yin and Yang. 185
Downregulation of nuclear-encoded genes of oxidative metabolism in dialyzed chronic kidney disease patients. 184
IDENTIFICAZIONE DI BIOMARCATORI MOLECOLARI PER LA DIAGNOSI PRECOCE DELLA FUNZIONALITÀ RITARDATA DELL'ORGANO TRAPIANTATO 183
The relationship between calcium kidney stones, arterial stiffness and bone density: unraveling the stone-bone-vessel liaison 183
Early creatinine shifts predict contrast-induced nephropathy and persistent renal damage after angiography. 182
99mTc-Ca-gluconate renal scintigraphy in patients with chronic renal failure 181
Everolimus-associated interstitial pneumonia in a renal transplant patient: a case report 181
La qualità della vita nell’anziano in dialisi [Quality of life of the elderly patient on dialysis]. 180
Extra-renal adverse effects of mTOR inhibitors: know them to optimize their use in renal transplantation. 180
NLRP3 Inflammasome Activation in Dialyzed Chronic Kidney Disease Patients. 180
An unusual association of contralateral congenital small kidney, reduced renal function and hyperparathyroidism in sponge kidney patients: on the track of the molecular basis. 179
Specific heparanase inhibition reverses glucose-induced mesothelial-to-mesenchymal transition. 179
Proteomic-based research strategy identified laminin subunit alpha 2 as a potential urinary-specific biomarker for the medullary sponge kidney disease. 179
Everolimus-induced epithelial to mesenchymal transition (EMT) in bronchial/pulmonary cells: when the dosage does matter in transplantation 179
The impact of pruritus on quality of life of patients undergoing dialysis: A single-center cohort study 178
Bedside Screening for Fistula Stenosis Should Be Tailored to the Site of the Arteriovenous Anastomosis 174
Familial clustering of medullary sponge kidney is autosomal dominant with reduced penetrance and variable expressivity. 174
Acute changes in renal function in IgA nephropathy 173
Metabolic Syndrome, Cardiovascular Disease, and Risk for Chronic Kidney Disease in an Italian Cohort: Analysis of the INCIPE Study. 173
Monoclonal antibody therapy and renal transplantation: focus on adverse effects. 173
Sirolimus and Everolimus Pathway: Reviewing Candidate Genes Influencing Their Intracellular Effects 172
Epithelial to mesenchymal transition in the liver field: the double face of Everolimus in vitro. 171
Assessment of physical performance and body composition in male renal transplant patients 171
Systemic and Nonrenal Adverse Effects Occurring in Renal Transplant Patients Treated with mTOR Inhibitors. 170
Impact of maintenance immunosuppressive therapy on the fecal microbiome of renal transplant recipients: Comparison between an everolimus- and a standard tacrolimus-based regimen. 169
Evaluation of hepcidin isoforms in hemodialysis patients by a proteomic approach based on SELDI-TOF MS 169
In search of an optimal bedside screening program for arteriovenous fistula stenosis 169
3 years' experience in the prevention of recurrent calcic nephrolithiasis 168
Hepcidin is not useful as a biomarker for iron needs in haemodialysis patients on maintenance erythropoiesis-stimulating agents 167
High chronic nephropathy detection yield in CKD subjects identified by the combination of albuminuria and estimated GFR. 165
Is it possible to use the identification of neutrophil gelatinase- associated lipocalin (NGAL) in the evaluation of bisphosphonates nephrotoxicity? [E' possibile utilizzare la determinazione della lipocalina associata alla gelatinasi dei neutrofili (NGAL) nella valutazione della nefrotossicità da bisfosfonati?] 165
Everolimus-induced epithelial to mesenchymal transition in immortalized human renal proximal tubular epithelial cells: key role of heparanase. 165
Genome-wide association studies identify genetic loci associated with albuminuria in diabetes. 165
In vitro effects of interleukin (IL)-1 beta inhibition on the epithelial-to-mesenchymal transition (EMT) of renal tubular and hepatic stellate cells. 165
How has peritoneal dialysis changed over the last 30 years: experience of the Verona dialysis center 165
GDNF gene Variants Associated with Medullary Sponge Kidney. Distinguish a Specific Clinical Phenotype. 164
Carbohydrate metabolism in patients with nephrotic syndrome and normal renal function 163
A validated model of disease progression in IgA nephropathy. 162
Heparanase: A Potential New Factor Involved in the Renal Epithelial Mesenchymal Transition (EMT) Induced by Ischemia/Reperfusion (I/R) Injury. 162
Altered thyroid in dialysed uremic patients 161
Heparanase is a key player in renal fibrosis by regulating TGF-β expression and activity. 161
Rapporti tra adattamento, qualità di vita e supporto familiare, sociale nel paziente in trattamento dialitico. [Dialysis, adaptation, quality of life, and family support.] 160
Unusual renal presentation of Fabry disease in a female patient. 160
Practice patterns in the management of arteriovenous fistula stenosis: a northern Italian survey. 158
Sclerostin and Dickkopf-1 in post-menopausal renal allograft recipients. 158
Renal lesions after unilateral ureterosigmoidostomy in the rabbit: preliminary results 157
Antihypertensive, hemodynamic and endocrine effects of Captopril in arterial hypertension 157
Post-renal transplant pregnancy: a project to plan carefully 157
Mitochondria: a new therapeutic target in chronic kidney disease. 157
ENDOTHELIAL PROGENITOR CELLS IN ACUTE RENAL INJURY 156
mTOR Inhibition Role in Cellular Mechanisms 156
Safety and Efficacy of Citrate Anticoagulation for Continuous Renal Replacement Therapy for Acute Kidney Injury After Liver Transplantation: A Single-Center Experience. 155
Ten years experience of CAPD in diabetics: comparison of results with non-diabetics. Italian Cooperative Peritoneal Dialysis Study Group 153
Procalcitonin values after dialysis is closely related to type of dialysis membrane 153
Sulodexide alone or in combination with low doses of everolimus inhibits the hypoxia-mediated epithelial to mesenchymal transition in human renal proximal tubular cells. 153
Medullary sponge kidney (Lenarduzzi-Cacchi-Ricci disease): A Padua Medical School discovery in the 1930s. 152
Personalization of the Immunosuppressive Treatment in Renal Transplant Recipients: The Great Challenge in "Omics" Medicine. 152
Pharmacogenetics: a promising tool to personalize immunosuppressive therapy in renal transplantation. 152
Red blood cells and platelet membrane fatty acids in non-dialyzed and dialyzed uremics 151
Cutaneous plasmacytoma in a hemodialysis patient. 151
Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function. 151
A type I interferon signature characterizes chronic antibody-mediated rejection in kidney transplantation. 151
Basi scientifiche per la definizione di linee guida in ambito clinico per i tumori della prostata 150
Early small creatinine shift predicts contrast-induced acute kidney injury and persistent renal damage after percutaneous coronary procedures 150
Should current criteria for detecting and repairing arteriovenous fistula stenosis be reconsidered? Interim analysis of a randomized controlled trial 149
Early dietary protein and phosphorus restriction is effective in delaying progression of chronic renal failure 148
Renal tubular defects in recurring bilateral nephrolithiasis 148
Heparanase regulates the M1 polarization of renal macrophages and their crosstalk with renal epithelial tubular cells after ischemia/reperfusion injury 148
Effects of high doses of frusemide on plasma and muscle electrolytes in patients with chronic renal failure 147
Heparanase and syndecan-1 interplay orchestrates fibroblast growth factor-2-induced epithelial-mesenchymal transition in renal tubular cells. 147
Precocious activation of genes of the renin-angiotensin system and the fibrogenic cascade in IgA glomerulonephritis. 146
Mantenimento del trapianto renale: impatto clinico a lungo termine di tre diversi protocolli immunosoppressivi Risultati di un ampio studio multicentrico italiano 146
Karyopherins: potential biological elements involved in the delayed graft function in renal transplant recipients. 146
Totale 17.720
Salva come PNG Salva come JPEG
Categoria #
all - tutte 121.118
article - articoli 110.700
book - libri 0
conference - conferenze 4.838
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 5.580
Totale 242.236
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021233 0 0 0 0 0 0 0 0 0 0 0 233
2021/20221.677 96 363 18 178 64 52 39 113 88 50 150 466
2022/20234.371 328 426 471 662 419 1.100 53 267 444 23 121 57
2023/20241.717 99 176 163 198 235 231 27 117 16 76 261 118
2024/20254.810 312 351 174 825 225 160 194 269 729 290 375 906
2025/202613.611 1.060 696 913 2.121 3.199 961 1.435 754 899 784 351 438
Totale 36.918